Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation
Mélanie Roland(Centre Hospitalier Universitaire de Tours), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Yvon Lebranchu(Académie Nationale de Médecine), Valérie Châtelet(Centre Hospitalier Universitaire de Caen Normandie), Hubert Nivet(Centre Hospitalier Universitaire de Tours), Christelle Barbet(Centre Hospitalier Régional Universitaire de Brest), Azmi Al-Najjar(Université de Tours), Matthias Büchler(Centre Hospitalier Universitaire de Tours), Jean-Frédéric Marlière(Université de Tours), Philippe Gatault(Centre Hospitalier Universitaire de Tours), Claire Doute(Centre Hospitalier Universitaire de Tours)
Cited by 63
Related Papers
Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination
|Nature Genetics|2003|643
The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome
|Nature Genetics|2007|495
Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome
|American Journal of Transplantation|2013|269
Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
|American Journal of Transplantation|2002|256
Spectrum of Mutations in Gitelman Syndrome
|Journal of the American Society of Nephrology|2011|239